Archive for September, 2008

 

EU Approval For Cymbalta In Generalised Anxiety Disorder

September 30th, 2008

The European Commission has approved the use of Cymbalta (duloxetine) in treating generalised anxiety disorder (GAD), paving the way for the drug to be launched in all 27 member-states of the European Union. The verdict will also allow Cymbalta to be marketed in Iceland, Liechtenstein and Norway. Jointly produced by Eli Lilly (U.S.) and Boehringer […]

Read full article | Comments Off

Obese And Overweight Teenagers More Likely To Have Considered Suicide

September 27th, 2008

Teenagers who are overweight or obese are more likely to have considered suicide than those who are a normal weight, according to new research presented at a meeting of the Royal College of Psychiatrists’ Child and Adolescent Faculty.
Researchers from the University of Liverpool measured the height and weight of 799 Year 9 students

Read full article | Comments Off

Importance Of Sex-specific Testing Shown In Anxiety Study

September 15th, 2008

An Australian study has flagged an important truth for the medical research community. Like their human counterparts, male and female mice are not only different, their respective genetic responses can often be the reverse of what you’d expect from pharmacological results. This has important ramifications for laboratory

Read full article | Comments Off